4
Changes in Ownership
Travere Therapeutics, Inc. Filed Acc 0001209191-20-007720
Director sold 2,500 shares at $16.62 ($41,550)
From the SEC's structured data for this filing
Trades in this filing
ASELAGE STEVE · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-05 | Sale : show line 1 in the form | −2,500 | $16.62 | $41,550 | 248,466 | D |
| Open-market sales · 2,500 sh · avg $16.62 · $41,550 | ||||||
Loading xslF345X03/doc4.xml…